Competition for methionine between fast-growing tumour cells and T cells in the tumour microenvironment has been reported to disrupt methionine metabolism inside CD8+ T cells, lowering intracellular levels of methionine and the methyl donor S-adenosylmethionine (SAM)13. The gene discussed is CD8A; the disease is neoplasm.